Direct Oral Anticoagulants vs Vitamin K Antagonists in Left Ventricular Thrombi: A Systematic Review and Meta-analysis

Direct Oral Anticoagulants vs Vitamin K Antagonists in Left Ventricular Thrombi: A Systematic Review and Meta-analysis

Background: There is increasing interest in direct oral anticoagulants (DOACs), given their safety and convenience in atrial fibrillation, compared with vitamin K antagonists (VKAs). However, the use of DOACs in left ventricular (LV) thrombi is considered off-label, with current guidelines recommend...

Full description

Bibliographic Details
Main Authors:	Faith Michael, MD, Navneet Natt, MD, Mohammed Shurrab, MD, MSc
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	CJC Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589790X21001153

Similar Items

Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
by: Hansa Iqbal, et al.
Published: (2020-10-01)

Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus
by: Lei Huang, et al.
Published: (2022-10-01)

Safety and Efficacy of Vitamin K Antagonists vs. Novel Oral Anticoagulants in Patients With Left Ventricular Thrombus: A Meta-Analysis
by: He Xuan, et al.
Published: (2021-04-01)

Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta‐analysis
by: Dhan B. Shrestha, et al.
Published: (2023-11-01)

Direct Oral Anticoagulants versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombosis: A Meta-Analysis
by: Jian Li, et al.
Published: (2022-09-01)

Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus.
by: Kazuhiko Kido, et al.
Published: (2021-01-01)

Left ventricular thrombi in a patient with left ventricular non-compaction in visualisation of the rationale for anticoagulation.
by: Petersen, SE, et al.
Published: (2005)

Trial sequential analysis of efficacy and safety of direct oral anticoagulants and vitamin K antagonists against left ventricular thrombus
by: Tetsuji Kitano, et al.
Published: (2023-08-01)

Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
by: Rimmy Garg, et al.
Published: (2022-06-01)

How to treat left ventricular thrombi- warfarin or direct oral anti-coagulants?
by: Pankaj Mathur, et al.
Published: (2022-01-01)

How to treat left ventricular thrombi - Warfarin or direct oral anti-coagulants?
by: Pankaj Mathur, et al.
Published: (2022-01-01)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
by: Fabrice F. Darche, et al.
Published: (2023-06-01)

Non-vitamin K antagonist oral anticoagulants for heart diseases
by: T B Kondratieva, et al.
Published: (2017-09-01)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
by: Frederique E. C. M. Peeters, et al.
Published: (2018-10-01)

Effect of direct oral anticoagulants versus vitamin K antagonists or warfarin in patients with left ventricular thrombus outcomes: A systematic review and meta-analysis
by: Hilaryano da Silva Ferreira, et al.
Published: (2023-01-01)

Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
by: Emma Kirstine Laugesen, et al.
Published: (2019-11-01)

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact
by: Eve Cariou, et al.
Published: (2021-11-01)

Anticoagulants in clinical practice. The place of vitamin K antagonists in combination with new oral anticoagulants
by: T. V. Vavilova
Published: (2015-12-01)

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants
by: Raphael Chinedu Anakwue
Published: (2020-01-01)

Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus
by: Qing Yang, et al.
Published: (2023-03-01)

Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis
by: Xinxing Gao, et al.
Published: (2022-05-01)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
by: Michele Malagù, et al.
Published: (2023-03-01)

Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis
by: Adel Khalifa Sultan Hamad
Published: (2022-01-01)

Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes
by: Andrea Rubboli
Published: (2013-12-01)

Kidney Function and the Use of Vitamin K Antagonists or Direct Oral Anticoagulants in Atrial Fibrillation
by: Gencheva Dolina
Published: (2023-09-01)

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
by: Kateryna Fedorov, et al.
Published: (2021-08-01)

Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis
by: Wei-Chieh Lee MD, et al.
Published: (2023-02-01)

Non-vitamin K antagonist oral anticoagulants in adults with congenital heart disease
by: Ji-Eun Ban
Published: (2022-09-01)

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis.
by: Giuseppe Santarpia, et al.
Published: (2015-01-01)

Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
by: Hyun-Jung Lee, et al.
Published: (2023-02-01)

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
by: Susin Park, et al.
Published: (2022-01-01)

Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study
by: Tsuyoshi Shiga, MD, et al.
Published: (2015-12-01)

Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage
by: Szu-Ju Chen, et al.
Published: (2020-01-01)

Vitamin-K Antagonists vs. Direct Oral Anticoagulants on Severity of Upper Gastrointestinal Bleeding: A Retrospective Analysis of Italian and UK Data
by: Mattia Brigida, et al.
Published: (2022-10-01)

Effects of direct oral anticoagulants vs. vitamin K antagonists on acute kidney injury in patients with atrial fibrillation: A systematic review
by: Chengfa Ren, et al.
Published: (2023-01-01)

Geriatric Conditions and Prescription of Vitamin K Antagonists vs. Direct Oral Anticoagulants Among Older Patients With Atrial Fibrillation: SAGE-AF
by: David D. McManus, et al.
Published: (2019-10-01)

Association of Direct Oral Anticoagulants vs. Vitamin K Antagonists With Fractures in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
by: Xiaojuan Wu, et al.
Published: (2021-07-01)

Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
by: Waltraud Pfeilschifter, et al.
Published: (2022-05-01)

Minimally Interrupted Non-Vitamin K Antagonist Oral Anticoagulants vs. Bridging Therapy and Uninterrupted Vitamin K Antagonists During Atrial Fibrillation Ablation: A Retrospective Single-Center Study
by: Lihong Tang, et al.
Published: (2020-06-01)